Across TCGA pan-cancer cohorts, LINC00482 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated LINC00482 data layer compared with 25 for mass-spec protein.
The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher LINC00482 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00482 expression acts as an unfavorable survival marker.
SKCM are the cancer types where LINC00482 Mutation most reproducibly stratifies survival.